Erratum: The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy (Breast Cancer Res Treat, 10.1007/s10549-010-1124-4);The management of ductal intraepithelial neoplasia (DIN): Open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy

Breast Cancer Research and Treatment

Volumn 128, Issue 2, 2011, Pages 369-378

  Farante, Gabriel ^a   Zurrida, Stefano ^a,b   Galimberti, Viviana ^a   Veronesi, Paolo ^a,b   Curigliano, Giuseppe ^a   Luini, Alberto ^a   Goldhirsch, Aron ^a   Veronesi, Umberto ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Breast cancer; Ductal intraepithelial neoplasia; Medical treatment; New agents; Radiotherapy; Surgery

Indexed keywords

ANASTROZOLE; ANTIESTROGEN; CYCLOOXYGENASE 2 INHIBITOR; DENDRITIC CELL VACCINE; ESTROGEN RECEPTOR; GEFITINIB; LAPATINIB; PLACEBO; PROTEIN TYROSINE KINASE INHIBITOR; RETINOID DERIVATIVE; TAMOXIFEN; TRASTUZUMAB;

ADJUVANT THERAPY; ARTICLE; AXILLARY LYMPH NODE; BREAST CALCIFICATION; BREAST CANCER; BREAST HYPERPLASIA; BREAST RECONSTRUCTION; BREAST TUMOR; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER INFILTRATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CONSERVATIVE TREATMENT; DISEASE FREE SURVIVAL; DRUG DOSE COMPARISON; EXCISION; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INTRADUCTAL CARCINOMA; INTRAOPERATIVE RADIOTHERAPY; ITALY; LOW DRUG DOSE; LYMPH NODE DISSECTION; MAMMOGRAPHY; MASTECTOMY; MULTICENTER STUDY (TOPIC); PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; REOPERATION; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; SINGLE DRUG DOSE; SURVIVAL TIME; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT;

EID: 79959711173     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1171-x     Document Type: Erratum

References (119)

1. FA Tavassoli 1998 Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia Mod Pathol 11 140 154 9504685 1:STN:280:DyaK1c7mtlaisQ%3D%3D (Pubitemid 28144150)
2. U Veronesi P Boyle A Goldhirsch, et al. 2005 Breast cancer Lancet 365 1727 1741 15894099 (Pubitemid 40719108)
3. U Veronesi G Viale N Rotmenz, et al. 2006 Rethinking TNM: breast cancer TNM classification for treatment decision-making and research Breast 15 3 8 16473737 (Pubitemid 43210543)
4. B Virnig T Tuttle T Shamliyan, et al. 2010 Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment and outcomes J Natl Cancer Inst 102 170 178 20071685
5. NN Baxter BA Virnig SB Durham, et al. 2004 Trends in the treatment of ductal carcinoma in situ of the breast J Natl Cancer Inst 96 443 448 15026469 (Pubitemid 38443647)
6. VL Ernster J Barclay K Kerlikowske, et al. 1996 Incidence of and treatment for ductal carcinoma in situ of the breast JAMA 275 913 918 8598618 1:STN:280:DyaK287nvVOmtA%3D%3D (Pubitemid 26095381)
7. E Ceilley R Jagsi S Goldberg, et al. 2004 The management of ductal carcinoma in situ in North America and Europe results of a survey Cancer 101 1958 1967 15389481 (Pubitemid 39425370)
8. SJ Katz PM Lantz NK Janz, et al. 2005 Patterns and correlates of local therapy for women with ductal carcinoma-in situ J Clin Oncol 23 3001 3007 15860856 (Pubitemid 46224120)
9. MM Aubele MC Cummings AE Mattis, et al. 2000 Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer Diagn Mol Pathol 9 14 19 10718208 1:STN:280:DC%2BD3c7otFWgtA%3D%3D (Pubitemid 30131957)
10. DC Allred GM Clark R Molina, et al. 1992 Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer Hum Pathol 23 974 979 1355464 1:STN:280:DyaK38zoslOjtA%3D%3D
11. M Rudas R Neumayer MFX Gnant, et al. 1997 p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast Eur J Cancer 33 39 44 9071897 1:CAS:528: DyaK2sXit1yitL8%3D (Pubitemid 27099565)
12. V Luzzi V Holtschlag MA Watson 2001 Expression profiling of ductal carcinoma in situ by laser capture microdissection and high-density oligonucleotide arrays Am J Pathol 158 2005 2010 11395378 1:CAS:528: DC%2BD3MXkvFyksLc%3D (Pubitemid 32545186)
13. A Seth R Kitching G Landberg, et al. 2003 Gene expression profiling of ductal carcinomas in situ and invasive breast tumors Anticancer Res 23 2043 2051 12894577 1:CAS:528:DC%2BD3sXmsFyrsLw%3D (Pubitemid 36897163)
14. DC Allred Y Wu A Tsimelzon, et al. 2002 The progression of DCIS to IBC: a cDNA expression microarray study Breast Cancer Res Treat 76 Suppl 1 S81
15. Allred DC (2002) Biologic characteristics of ductal carcinoma in situ. In: Silverstein MJ (ed) Ductal carcinoma in situ of the breast, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 37-48
16. OT Lampejo DM Barnes P Smith RR Millis 1994 Evaluation of infiltrating ductal carcinomas with a DCIS component: correlation of the histologic type of the in situ component with grade of the infiltrating component Semin Diagn Pathol 11 215 222 7831533 1:STN:280:DyaK2M7jt1yquw%3D%3D (Pubitemid 24308082)
17. H Buerger F Otterbach R Simon, et al. 1999 Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes J Pathol 189 521 526 10629552 1:CAS:528: DC%2BD3cXltlSkug%3D%3D
18. ER Fisher R Leeming S Anderson, et al. 1991 Conservative management of intraductal carcinoma (DCIS) of the breast J Surg Oncol 47 139 147 1649353 1:STN:280:DyaK3Mzgtl2qug%3D%3D
19. GF Schwartz L Solin I Olivotto, et al. 2000 Consensus conference on the treatment classification of ductal carcinoma in situ of the breast, April 22-25, 1999 Cancer 68 946 954 (Pubitemid 30091115)
20. MJ Silverstein BF Cohlan ED Gierson, et al. 1992 Ductal carcinoma in situ: 228 cases without microinvasion Eur J Cancer 28 630 634 1317201 1:STN:280:DyaK383ntlensg%3D%3D
21. A Guerreri-Gonzaga E Botteri N Rotmensz, et al. 2009 Ductal intraepithelial neoplasia: postsurgical out come for 1267 woman cared for in one single institution over 10 years Oncologist 14 201 212
22. GL Schmidt BD Schmidt BG Haffty 2006 Rationalization and regionalization of treatments for DCIS of the breast Int J Radiat Oncol Biol Phys 65 1397 1403 (Pubitemid 44425216)
23. HM Kuerer C Albarracin NT Yang, et al. 2008 DCIS: state of the science and roadmap to advance the field J Clin Oncol 27 279 288 19064970
24. ER Fisher J Dignam E Tan-Chiu, et al. 1999 Pathologic findings from the NSABP eight years update of protocol B-17: intraductal carcinoma Cancer 86 429 438 10430251 1:STN:280:DyaK1Mzlslehsg%3D%3D (Pubitemid 29347405)
25. Allred DC (2005) Ductal carcinoma in situ of the breast: pathologic and biologic perspectives. American Society of Clinical Oncology 2005 educational book 41st annual meeting, May 13-17, pp 75-79
26. NQ Mirza G Vlastos F Meric, et al. 2000 Ductal carcinoma-in situ: long-term results of breast conserving therapy Ann Surg Oncol 7 656 664 11034242 1:STN:280:DC%2BD3cvosFGrsA%3D%3D
27. B Fisher J Dignam N Wolmark, et al. 1999 Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomized controlled trial Lancet 353 1993 2000 10376613 1:CAS:528:DyaK1MXkt1Cnsrk%3D (Pubitemid 29271743)
28. N Bijker JL Peterse L Duchateau, et al. 2001 Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma in-situ: analysis of European organization for research and treatment of cancer trial 10853 J Clin Oncol 19 2263 2271 11304780 1:STN:280:DC%2BD3M3mtFOhtQ%3D%3D (Pubitemid 32366979)
29. K Kerlikowske A Molinaro I Cha, et al. 2003 Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy J Natl Cancer Inst 95 1692 1702 14625260 (Pubitemid 37509078)
30. MJ Silverstein MD Lagios S Groshen, et al. 1999 The influence of margin width on local control of ductal carcinoma in situ of the breast N Engl J Med 340 1455 1461 10320383 1:STN:280:DyaK1M3ktVShtw%3D%3D (Pubitemid 29220544)
31. J Thomas A Evans J Macartney, et al. 2010 Radiological and pathological side estimations of pure ductal carcinoma in situ of the breast: a review of 2564 cases from the Sloane Project Br J Cancer 102 285 293 20051953 1:STN:280:DC%2BC3c%2Fkt12jug%3D%3D
32. A Monteau B Sigal-Zafrani YM Kirova, et al. 2009 Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage Int J Radiat Oncol Biol Phys 75 1021 1028 19386441
33. Radiation Therapy Oncology Group (2004) RTOG 98-04. Phase III trial of observation ± tamoxifen vs. RT ± tamoxifen for good risk ductal carcinoma in situ (DCIS) of the female breast
34. G Leonard S Swain 2004 Ductal carcinoma in situ, complexities and challenges J Natl Cancer Inst 96 906 920 15199110 (Pubitemid 38868137)
35. LL Hughes M Wang DL Page 2009 Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group J Clin Oncol 27 5319 5324 19826126
36. Harris JR (2005) Radiotherapeutic considerations for DCIS. In: American Society of Clinical Oncology. 2005 educational book 41st annual meeting, May 13-17, 2005, pp 69-74
37. E Vincens K Alves B Lauratet, et al. 2008 Margin status in ductal carcinoma in situ of the breast Bull Cancer 95 1155 1159 19091648 1:STN:280:DC%2BD1M%2FjvVehsg%3D%3D
38. K Mokbel B Cutuli 2006 Heterogeneity the ductal carcinoma in situ and its effects of managements Lancet Oncol 7 756 765 16945771 (Pubitemid 44283669)
39. M Morrow 2009 Breast conservation and negative margins: how much is enough? Breast 18 Suppl 3 S84 S86 19914549
40. C Dunne JP Burke M Morrow, et al. 2009 Effect of the margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ J Clin Oncol 27 1615 1620 19255332
41. RE Mansell 2003 Ductal carcinoma in situ: surgery and radiotherapy Breast 12 447 450
42. A Goldhirsch JN Ingle RD Gerlber, et al. 2009 Thresholds for the therapies: highlights of the Saint Gallen International Expert Consensus, on the primary therapy of early breast cancer Ann Oncol 20 8 1319 1329 19535820 1:STN:280:DC%2BD1Mrjtlyhug%3D%3D
43. B Fisher J Constantino C Redmond, et al. 1993 Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer N Engl J Med 328 1581 1586 8292119 1:STN:280:DyaK3s3lsVCqug%3D%3D (Pubitemid 23151917)
44. JC Boughey RJ Gonzalez E Bonner, et al. 2007 Current treatment and clinical trial developments for ductal carcinoma in situ of the breast Oncologist 12 1276 1287 18055847 1:CAS:528:DC%2BD1cXivVSiug%3D%3D (Pubitemid 350232601)
45. ME Sanders PA Schuyler MO Dupont DL Page 2005 The natural history of low-grade DCIS of the breast in women treated by biopsy only revealed over 30 years long-terms follow-up Cancer 103 12 2481 2484 15884091 (Pubitemid 40800525)
46. MJ Silverstein MD Lagios S Martino, et al. 1998 Outcome after invasive LR in patients with ductal carcinoma in situ of the breast J Clin Oncol 16 1367 1373 9552039 1:STN:280:DyaK1c3htFOltw%3D%3D (Pubitemid 28175753)
47. LJ Solin B McCormick A Recht, et al. 1996 Mammographically detected clinically occult ductal carcinoma in situ (intraductal carcinoma) treated with breast conserving surgery and definitive breast irradiation Cancer J Sci Am 2 158 165 9166516 1:STN:280:DC%2BD28rnt1OmtQ%3D%3D
48. VL Ernster J Barclay K Kerlikowske, et al. 2000 Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program Arch Intern Med 160 953 957 10761960 1:STN:280:DC%2BD3c3it1GqtQ%3D%3D
49. LA Lee MJ Silverstein CT Chung, et al. 2006 Breast cancer specific mortality after invasive local recurrence in patients with duct carcinoma in site of the breast Am J Surg 192 416 419 16978940 (Pubitemid 44344203)
50. ER Fisher J Costantino B Fisher, et al. 1995 Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17. Intraductal carcinoma (ductal carcinoma in situ) Cancer 75 1310 1319 7882281 1:STN:280:DyaK2M7ovVWisA%3D%3D
51. E Fisher S Land R Seeda, et al. 2007 Pathologic variables predictive of breast events in patients with DCIS Am J Clin Pathol 128 86 94 17580274
52. E Mamounas B Fisher J Dingam, et al. 1997 Effects of breast irradiation following lumpectomy in intraductal carcinoma (DCIS): updated results from NSABP B-17 Proc Soc Surg Oncol 50 7
53. FA Vicini A Recht 2002 Age at diagnosis and outcome for women with ductal carcinoma in situ of the breast. A critical review of the literature J Clin Oncol 20 2736 2744 12039936 (Pubitemid 34575647)
54. LC Collins N Achacoso L Nekhlyudof 2009 Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients Am J Surg Pathol 33 1802 1808 19950406
55. A Turaka GM Freedman T Li, et al. 2009 Young age is not associated with increased local recurrence for DCIS treated by breast-conservation surgery and radiation J Surg Oncol 100 25 31 19373863
56. MJ Silverstein C Buchanan 2003 Ductal carcinoma in situ: USC/Van Nuys Prognostic Index and the impact of margin status Breast 12 457 471 14659122 (Pubitemid 38008660)
57. G Farante S Zurrida V Galimberti, et al. 2010 No more axillary dissection in patients with ductal intraepithelial neoplasia (DIN) Eur J Cancer 46 476 478 20097064
58. DP Winchester HR Menck RT Osteen, et al. 1995 Treatment trends for ductal carcinoma in situ of the breast Ann Surg Oncol 2 207 213 7641016 1:STN:280:DyaK2MzmvVCgtQ%3D%3D
59. M Porembka RL Abraham JA Sefko, et al. 2008 Factors associated with lymph node assessment in DCIS: analysis of 1988-2002 seer data Ann Surg Oncol 15 2709 2719 18483831
60. Bishop H, Kearins O, Lawrence G et al. (2008) Significant variation in the management of non invasive breast carcinoma in the UK: initial findings from the Sloane Project, a UK national prospective audit. In: Proceedings of the 9th annual meeting of the American Society of Breast Surgeons, April 30-May 4, p 31
61. B Cutuli C Lemanski A Fourquet, et al. 2009 Breast conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French survey experience Br J Cancer 100 1048 1054 19277037 1:STN:280: DC%2BD1M3kslektQ%3D%3D
62. SB Edge DG Sheldon 2003 Counterpoint: sentinel lymph node biopsy is not indicated for ductal carcinoma in situ J Natl Compr Canc Netw 1 207 212 19768879
63. S Pendas E Dauway R Giuliano, et al. 2007 Sentinel node biopsy in ductal carcinoma in situ patients Ann Surg Oncol 7 15 20
64. B Ansari SA Ogston CA Purdie, et al. 2008 Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast Br J Surg 95 547 554 18386775 1:STN:280:DC%2BD1c3ks1altg%3D%3D
65. M Intra P Veronesi G Mazzarol, et al. 2003 Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast Arch Surg 138 309 313 12611580 (Pubitemid 36292666)
66. HS Cody 2007 Sentinel lymph node biopsy for breast cancer: Indications, contraindications, and new directions J Surg Oncol 95 440 442 17458860
67. TB Julian SR Land V Fourchette, et al. 2007 Is sentinel node biopsy necessary in conservately treated DCIS? Ann Surg Oncol 14 2202 2208 17534687 (Pubitemid 47174907)
68. M Yi S Krishnamurthy HM Kuerer, et al. 2008 Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer Am J Surg 196 81 87 18436181 (Pubitemid 351847763)
69. F Dominguez M Golshan D Black, et al. 2008 SLN biopsy is important in mastectomy for DCIS Ann Surg Oncol 15 268 273 17891441
70. M Intra N Rotmentz D Mattar, et al. 2007 Unnecessary axillary node dissections in the sentinel lymph node era Eur J Cancer 43 2664 2668 17931853 (Pubitemid 350151839)
71. EA Mittendorf CA Arciero V Guttchell, et al. 2005 Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy Curr Surg 62 253 257 15796952 (Pubitemid 40425295)
72. ME El Sayed WA Rakha J Reed, et al. 2008 Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening Hystopathology 53 650 657 1:STN:280:DC%2BD1M%2FivV2ruw%3D%3D (Pubitemid 352768713)
73. FA Sakr R Bezu C Raoust, et al. 2008 The sentinel lymph node procedure for patients with preoperative diagnosis of ductal carcinoma in situ: risk factors for unsuspected invasive disease and for metastatic sentinel lymph nodes Int J Clin Pract 62 1730 1735 19143859 1:STN:280:DC%2BD1M%2Fnt1WhtA%3D%3D
74. TW Yen KK Hunt MI Ross, et al. 2005 Predictors of invasive breast cancer of an initial diagnosis of DCIS. A guide in the selective use of sentinel lymph node biopsy in management of DCIS J Am Coll Surg 200 516 526 15804465 (Pubitemid 40432319)
75. O Fadare NF Clement M Ghofrani 2009 High and intermediate grade ductal carcinoma in situ of the breast: a comparison of pathologic features in core biopsies and excisions and an evaluation of core biopsy features that may predict a close of positive margin in the excision Diagn Pathol 4 26 31 19691836
76. EA O'Flynn JC Morel J Gonzales, et al. 2009 Prediction of the presence of invasive disease from the measurement of extent of malignant micro-calcifications on mammography and ductal carcinoma in situ grade at core biopsy Clin Radiol 64 178 183 19103348
77. B Doyle M al-Mudhaffer MM Kennedy, et al. 2009 Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified? J Clin Pathol 62 534 538 19190009 1:STN:280: DC%2BD1MzntlSlsQ%3D%3D
78. CD Murphy JL Jones S Hughes Javid, et al. 2008 Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion? Am J Surg 196 566 568 18760400
79. K Moore K Sweeney M Wilson, et al. 2005 Outcomes for women with DCIS and positive sentinel node: a multi-institutional audit Ann Surg Oncol 14 2911 2917 (Pubitemid 47460624)
80. C Tunon-de-Lara S Giard M Buttarelli, et al. 2008 Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma treated by mastectomy Breast J 14 135 140 18315691 (Pubitemid 351341834)
81. M Leidenius K Salmenkivi K von Smitten, et al. 2006 Tumour-positive sentinel node findings in patients with ductal carcinoma in situ J Surg Oncol 94 380 384 16967467 1:STN:280:DC%2BD28rlsVygtw%3D%3D (Pubitemid 44465341)
82. NIH State-of-the-Science Conference Statement (2009) Diagnosis and management of DCIS. September 22-24
83. Bryan J, Land S, Allred C et al. (2003) DCIS: evidence from randomized trials. Proceedings of the 8th international conference March 12-15, 2003, St Gallen, Switzerland. Breast 12(Suppl. 1):S9 (S24)
84. N Bijker P Meijnen JL Peterse, et al. 2006 Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: ten-year results of European organisation for research and treatment of cancer randomized phase III trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotheraphy Group J Clin Oncol 24 3381 3387 16801628 (Pubitemid 46638893)
85. J Houghton WD George J Cuzick, et al. 2003 UK Coordinating Committee on Cancer Research: radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial Lancet 362 95 102 12867108 (Pubitemid 36831018)
86. SO Emdin B Grandstrand A Ringberg, et al. 2006 SwDCIS: radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomized trial in a population offered mammography screening Acta Oncol 45 536 543 16864166 (Pubitemid 44167203)
87. Goodwin A, Parker S, Ghersi D et al. (2009) Post-operative radiotherapy for ductal carcinoma in situ of the breast. Cochrane Database Syst Rev (4):CD000563
88. JS Wong CM Kaelin SL Troyan, et al. 2006 Prospective study of wide excision alone for ductal carcinoma in situ of the breast J Clin Oncol 24 7 1031 1036 16461781 (Pubitemid 46638798)
89. LJ Solin 2006 Is excision alone adequate treatment for low-risk ductal carcinoma in situ of the breast? J Clin Oncol 24 1017 1019 16461780 (Pubitemid 46638793)
90. M Silverstein A Retch M Lagios, et al. 2009 Image-detected breast cancer: state-of-the-art diagnosis and treatment Am Coll Surg 209 504 520
91. A Omlin M Amichetti D Azria, et al. 2006 Boost radiotherapy in young women with DCIS: a multicentre, retrospective study of the Rare Cancer Network Lancet Oncol 7 652 656 16887482 (Pubitemid 44143777)
92. D Azria H Auvray I Barillot, et al. 2008 Ductal carcinoma in situ: role of the boost Cancer Radiother 12 571 576 18703372 1:STN:280: DC%2BD1cjhs1SntA%3D%3D
93. B Smith A Douglas TA Buchholz, et al. 2009 Accelerated partial breast irradiation consensus statement from the American society for radiation oncology (ASTRO) Int J Rad Oncol Biol Phys 74 987 1001
94. M Keisch F Vicini P Beitsch, et al. 2009 American Society of Breast Surgeons Mammosite Radiation Therapy System registry trial: ductal carcinoma in situ subset analysis-4 year data in 194 treated lesions Am J Surg 198 505 507 19800456
95. JY Petit U Veronesi R Orecchia, et al. 2009 Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: 1001 cases of a five years experience at the European Institute of Oncology in Milan (EIO) Breast Cancer Res Treat 117 333 338 19152026 1:STN:280:DC%2BD1MrlsVyitA%3D%3D
96. C Garcia-Etienne H Cody III J Dosa, et al. 2009 Nipple-sparing mastectomy: initial experience at the Memorial Sloan-Kettering Cancer Center and a comprehensive review of literature Breast J 15 440 449 19496781
97. E Brachtel E Rusby J Michaelson, et al. 2009 Occult nipple involvement in breast cancer: clinicopathologic findings in 319 consecutive mastectomy specimens J Clin Oncol 27 4930 4932
98. NLP Barnes G Boland A Davenport, et al. 2003 A prospective study of estrogen and progesterone receptor status in ductal carcinoma-in situ Breast Cancer Res Treat 82 Suppl 1 S34
99. A Decensi C Robertson G Viale, et al. 2003 A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers J Natl Cancer Inst 95 11 779 790 12783932 1:CAS:528:DC%2BD3sXksVWqtr8%3D (Pubitemid 36798424)
100. A Decensi S Gandini D Serrano, et al. 2007 Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users J Clin Oncol 25 27 4201 4209 17709798 1:CAS:528:DC%2BD2sXhtFyis7vJ (Pubitemid 47548559)
101. VG Vogel JP Costantino DL Wickerham, et al. 2006 Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial JAMA 295 2727 2741 16754727 1:CAS:528:DC%2BD28XmtFOltLc%3D
102. TW Yen KK Hunt NQ Mirza, et al. 2004 Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ Cancer 100 942 949 14983489 1:CAS:528:DC%2BD2cXitlehsL8%3D (Pubitemid 38222854)
103. A Howell A Buzdar 2005 Are aromatase inhibitors superior to antiestrogens? J Steroid Biochem Mol Biol 93 237 247 15860266 1:CAS:528:DC%2BD2MXjs1Cru7w%3D (Pubitemid 40602496)
104. K Subbaramaiah L Norton W Gerald, et al. 2002 Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3 J Biol Chem 277 18649 18657 11901151 1:CAS:528: DC%2BD38XktFChs7s%3D (Pubitemid 34952420)
105. E Half XM Tang K Gwyn, et al. 2002 Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinomas in situ Cancer Res 62 1676 1681 11912139 1:CAS:528:DC%2BD38XisVSisb4%3D (Pubitemid 34408488)
106. Lowenfels A (2008) Ductal carcinoma in situ: evolving strategies to optimal diagnosis and management. In: Proceedings of the 93rd annual clinical congress of the American College of Surgeons
107. Neoadjuvant Herceptin for Ductal Carcinoma in Situ of the Breast. (2008) Clinical trials gov identifier NCT00496808
108. K Altundag 2005 Challenge in the treatment of estrogen-receptor-negative ductal carcinoma in situ J Clin Oncol 23 2 357 367
109. KC Chan WF Knox JG Gee, et al. 2002 Effect of epidermal growth factor receptor tyrosine kinase inhibition on epithelial proliferation in normal and premalignant breast Cancer Res 62 122 128 11782368 1:CAS:528: DC%2BD38XntV2isA%3D%3D (Pubitemid 34073995)
110. JC Newby SR Johnston IE Smith, et al. 1997 Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer Clin Cancer Res 3 1643 1651 9815855 1:STN:280: DyaK1M7htFWjtg%3D%3D (Pubitemid 27431575)
111. Y Noguchi A Jungbluth EC Richards LJ Old 1996 Effect of interleukin 12 on tumor induction by 3-methylcholanthrene Proc Natl Acad Sci USA 93 11798 11801 8876217 1:CAS:528:DyaK28Xmtlantrs%3D (Pubitemid 26347203)
112. T Iinuma S Homma T Noda, et al. 2004 Prevention of gastrointestinal tumours based on adenomatous polyposis coli gene mutation by dendritic cell vaccine J Clin Invest 113 1307 1317 15124022 1:CAS:528:DC%2BD2cXjvVOqs7w%3D (Pubitemid 39069930)
113. JW Greiner H Zeytin MR Anver J Schlom 2002 Vaccine-based therapy directed against carcinoembryonic antigen demonstrates antitumor activity on spontaneous intestinal tumors in the absence of autoimmunity Cancer Res 62 6944 6951 12460911 1:CAS:528:DC%2BD38XpsVahsLk%3D (Pubitemid 35424085)
114. J Xia Y Tanaka S Koido, et al. 2003 Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic/tumor fusion cells J Immunol 170 1980 1986 12574367 1:CAS:528:DC%2BD3sXht12iurg%3D (Pubitemid 36197418)
115. E Quaglino 2004 Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions J Clin Invest 113 709 717 14991069 1:CAS:528:DC%2BD2cXhvFOks7Y%3D (Pubitemid 38544164)
116. P Nanni SM Pupa G Nicoletti, et al. 2000 p185(neu) protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinoma Int J Cancer 87 186 194 10861472 1:CAS:528:DC%2BD3cXltV2rsb8%3D (Pubitemid 30434343)
117. BJ Czerniecki GK Koski U Koldowsky, et al. 2007 Targeting Her-2/new in early breast cancer development using dendritic cells with staged interleukin-12 burst excretion Cancer Res 64 1842 1852 (Pubitemid 46383411)
118. K Liang W Jin Y Lu, et al. 2003 Targeting Her2 as an approach for sensitizing breast cancer cells to radiotherapy Proc Am Assoc Cancer Res 44 155
119. C De Cicco M Pizzamiglio G Trifirò, et al. 2002 Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer. Technical aspects Q J Nucl Med 46 2 145 151 12114878